Today: 13 June 2026
Browse Category

Dividends 26 September 2025 - 2 October 2025

Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer shares closed at $23.60 on Sept. 25, 2025, down 9% year-to-date and 18% from a year ago, near the bottom of their 52-week range. The dividend yield has risen above 7% as the stock slumped. In September, Pfizer announced a $7.3 billion acquisition of Metsera and reported strong Phase 3 results for a new COVID-19 vaccine. A key court hearing on Depo-Provera lawsuits is set for Sept. 29.
1 41 42 43

Stock Market Today

  • Teradyne Surges 5.7% Ahead of Nasdaq-100 Inclusion on June 22
    June 13, 2026, 5:47 PM EDT. Teradyne shares rose 5.72% to $403.20 after Nasdaq announced its addition to the Nasdaq-100 index before June 22's open. This move often triggers demand from index funds that track the benchmark, potentially boosting the stock price. Teradyne's market cap is about $63.6 billion, near its 52-week high. The chip-testing company reported a record Q1 revenue of $1.282 billion, up 87% year-on-year, with about 70% tied to AI-related demand. However, the stock trades at a high trailing P/E ratio of 75, with analyst price targets below Friday's close. Investors will watch for index-linked buying around the rebalance date to assess if the rally continues or experiences a pullback.

Latest articles

Boeing Shares Dip After Report of Air India 737 Delivery Delay

Boeing Shares Dip After Report of Air India 737 Delivery Delay

13 June 2026
Boeing shares fell 1.16% to $219.05 Friday, underperforming a rising market, after reports that Air India wants to defer hundreds of jet deliveries added fresh uncertainty to Boeing’s cash-flow recovery, with investors now focused on June delivery data and 737 production rates as the next key catalyst for the stock.
IonQ Stock Near $58: $100 Analyst Target Meets Quantum Valuation Risk

IonQ Stock Near $58: $100 Analyst Target Meets Quantum Valuation Risk

13 June 2026
IonQ closed Friday at $57.85, down 0.24%, with a $21.5 billion market cap as analysts maintain mixed-to-bullish ratings and a $64.69 consensus target; investors await Q2 results and SkyWater deal progress, with valuation risk high at 81 times 2026 revenue guidance and adjusted EBITDA loss guidance reaffirmed at $310–$330 million.
Go toTop